Smart Insulin Pen Market, By Indication (Type 1 Diabetes, Type 2 Diabetes), By Connectivity (Bluetooth, USB), By Distribution Channel (Clinics and Ambulatory Surgical Centers, e-Commerce, Retail Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jul 2023

Code : CMI3436

Pages :105

Formats :

Excel and PDF

Industry : Medical Devices

Regional Analysis

Global Smart Insulin Pen Market - Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global smart insulin pen market over the forecast period. The growing prevalence of geriatric population directly impacts the increased demand for the smart insulin pen market for easy tracking of data. For instance, according to data shared by Endocrine Society on January 24, 2022, 54.1 million adults or 16.3% of the U.S. population are seniors (aged 65 or older). An estimated 33% of adults aged 65 or older have diabetes. This population is more at risk of developing diabetes-related complications such as hypoglycemia (low blood sugar), kidney failure, and heart disease than younger people living with diabetes.

North America: U.S. and Canada

Latin America: Brazil, Argentina, Mexico, and Rest of Latin America

Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe

Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific

Middle East: GCC Countries, Israel, and Rest of Middle East

Africa: South Africa, North Africa, and Central Africa